301 related articles for article (PubMed ID: 21241214)
1. Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.
Persaud D; Bedri A; Ziemniak C; Moorthy A; Gudetta B; Abashawl A; Mengistu Y; Omer SB; Isehak A; Kumbi S; Adamu R; Lulseged S; Ashworth R; Hassen E; Ruff A;
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):823-9. PubMed ID: 21241214
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants.
Moorthy A; Gupta A; Bhosale R; Tripathy S; Sastry J; Kulkarni S; Thakar M; Bharadwaj R; Kagal A; Bhore AV; Patil S; Kulkarni V; Venkataramani V; Balasubramaniam U; Suryavanshi N; Ziemniak C; Gupte N; Bollinger R; Persaud D
PLoS One; 2009; 4(1):e4096. PubMed ID: 19119321
[TBL] [Abstract][Full Text] [Related]
3. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
Kurle SN; Gangakhedkar RR; Sen S; Hayatnagarkar SS; Tripathy SP; Paranjape RS
AIDS Res Hum Retroviruses; 2007 May; 23(5):682-5. PubMed ID: 17530993
[TBL] [Abstract][Full Text] [Related]
4. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
Eshleman SH; Mracna M; Guay LA; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson LM; Mmiro F; Jackson JB
AIDS; 2001 Oct; 15(15):1951-7. PubMed ID: 11600822
[TBL] [Abstract][Full Text] [Related]
5. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
[TBL] [Abstract][Full Text] [Related]
6. Quantifying the impact of nevirapine-based prophylaxis strategies to prevent mother-to-child transmission of HIV-1: a combined pharmacokinetic, pharmacodynamic, and viral dynamic analysis to predict clinical outcomes.
Frank M; von Kleist M; Kunz A; Harms G; Schütte C; Kloft C
Antimicrob Agents Chemother; 2011 Dec; 55(12):5529-40. PubMed ID: 21947390
[TBL] [Abstract][Full Text] [Related]
7. Analysis of nevirapine resistance in HIV-infected infants who received extended nevirapine or nevirapine/zidovudine prophylaxis.
Fogel J; Hoover DR; Sun J; Mofenson LM; Fowler MG; Taylor AW; Kumwenda N; Taha TE; Eshleman SH
AIDS; 2011 Apr; 25(7):911-7. PubMed ID: 21487249
[TBL] [Abstract][Full Text] [Related]
8. Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.
Lehman DA; Wamalwa DC; McCoy CO; Matsen FA; Langat A; Chohan BH; Benki-Nugent S; Custers-Allen R; Bushman FD; John-Stewart GC; Overbaugh J
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):225-33. PubMed ID: 22395670
[TBL] [Abstract][Full Text] [Related]
9. Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
Toni TD; Masquelier B; Lazaro E; Dore-Mbami M; Ba-Gomis FO; Téa-Diop Y; Kouakou K; Diby J; Sia E; Soppi S; Essien S; Schrive MH; Pinson P; Chenal H; Fleury HJ
AIDS Res Hum Retroviruses; 2005 Dec; 21(12):1031-4. PubMed ID: 16379606
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine resistance after single dose prophylaxis.
Eshleman SH; Jackson JB
AIDS Rev; 2002; 4(2):59-63. PubMed ID: 12152519
[TBL] [Abstract][Full Text] [Related]
11. Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.
Martinson NA; Morris L; Gray G; Moodley D; Pillay V; Cohen S; Dhlamini P; Puren A; Bhayroo S; Steyn J; McIntyre JA
J Acquir Immune Defic Syndr; 2007 Feb; 44(2):148-53. PubMed ID: 17117145
[TBL] [Abstract][Full Text] [Related]
12. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.
Arrivé E; Newell ML; Ekouevi DK; Chaix ML; Thiebaut R; Masquelier B; Leroy V; Perre PV; Rouzioux C; Dabis F;
Int J Epidemiol; 2007 Oct; 36(5):1009-21. PubMed ID: 17533166
[TBL] [Abstract][Full Text] [Related]
14. In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
Church JD; Mwatha A; Bagenda D; Omer SB; Donnell D; Musoke P; Nakabiito C; Eure C; Bakaki P; Matovu F; Thigpen MC; Guay LA; McConnell M; Fowler MG; Jackson JB; Eshleman SH
AIDS Res Hum Retroviruses; 2009 Jul; 25(7):673-7. PubMed ID: 19552593
[TBL] [Abstract][Full Text] [Related]
15. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
16. Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
Eshleman SH; Guay LA; Mwatha A; Cunningham SP; Brown ER; Musoke P; Mmiro F; Jackson JB
AIDS Res Hum Retroviruses; 2004 Jun; 20(6):595-9. PubMed ID: 15242535
[TBL] [Abstract][Full Text] [Related]
17. Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
Church JD; Omer SB; Guay LA; Huang W; Lidstrom J; Musoke P; Mmiro F; Jackson JB; Eshleman SH
J Infect Dis; 2008 Oct; 198(7):1075-82. PubMed ID: 18684096
[TBL] [Abstract][Full Text] [Related]
18. Greater suppression of nevirapine resistance with 21- vs 7-day antiretroviral regimens after intrapartum single-dose nevirapine for prevention of mother-to-child transmission of HIV.
McMahon DK; Zheng L; Hitti J; Chan ES; Halvas EK; Hong F; Kabanda J; Taulo F; Kumarasamy N; Bonhomme J; Wallis CL; Klingman KL; Hughes MD; Mellors JW
Clin Infect Dis; 2013 Apr; 56(7):1044-51. PubMed ID: 23300238
[TBL] [Abstract][Full Text] [Related]
19. Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
Flys TS; Mwatha A; Guay LA; Nakabiito C; Donnell D; Musoke P; Mmiro F; Jackson JB; Eshleman SH
AIDS; 2007 Oct; 21(15):2077-82. PubMed ID: 17885298
[TBL] [Abstract][Full Text] [Related]
20. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
Lidström J; Li Q; Hoover DR; Kafulafula G; Mofenson LM; Fowler MG; Thigpen MC; Kumwenda N; Taha TE; Eshleman SH
AIDS; 2010 Jan; 24(3):381-6. PubMed ID: 19996936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
